Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nexalin Technology (NXL) Research & Development (2024 - 2025)

Nexalin Technology has reported Research & Development over the past 2 years, most recently at $224940.0 for Q4 2025.

  • Quarterly results put Research & Development at $224940.0 for Q4 2025, down 69.49% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (down 9.02% YoY), and the annual figure for FY2025 was $1.1 million, down 9.02%.
  • Research & Development for Q4 2025 was $224940.0 at Nexalin Technology, down from $226520.0 in the prior quarter.
  • Over the last five years, Research & Development for NXL hit a ceiling of $737242.0 in Q4 2024 and a floor of $105668.0 in Q1 2024.